Aurobindo Promoters Raise 2,000 Cr for Realty Acquisitions

Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed

Cadila Pharmaceuticals Unveils Dlorfast-M for Allergy Relief

Cadila Pharmaceuticals, one of the leading research-based pharmaceutical companies in India, has now launched Dlorfast-M Tablets. It is a new fixed-dose combination tablet that contains 5 mg of Desloratadine (a novel antihistamine) and 10 mg...

Orbital Therapeutics acquired by BMS for $1.5B RNA tech.

Orbital Therapeutics, a privately held biotech company, was purchased by Bristol Myers Squibb (BMS) for $1.5 billion in cash. The agreement, which was made public on October 10, 2025, gives BMS access to Orbital's exclusive RNA-based platform and

PharmaTech & LabTech Expo 2025 Heads to Bengaluru

From December 19 to 21, 2025, the 21st PharmaTech Expo & LabTech Expo will be held at the Bengaluru International Exhibition Centre (BIEC), Bengaluru, in conjunction with the Contract Manufacturing and Raw & Packaging Material Expo. Professionals

Dr. Reddy's, Zydus Recall Drugs in US over Quality Issues

The US health agency has said that Zydus Lifesciences and Dr. Reddy's Laboratories, two major drug companies, are recalling their goods in the US due to production problems

WHO Assembles GDG to Tackle HTLV-1 Testing and Prevention

A Guideline Development Group (GDG) is being assembled by the World Health Organization (WHO) to create evidence-based guidelines for human T-cell lymphotropic virus-1 (HTLV-1)

AstraZeneca and Turbine Partner to Advance ADC Discovery

Turbine, a prominent company focused on the virtualization of biological experiments using AI, has announced a partnership with AstraZeneca to evaluate the capability of Turbine’s platform in rationalizing the discovery of antibody-drug conjugates

Bayer, Kumquat Launch Trial for KRAS G12D Cancer Drug

Bayer and Kumquat Biosciences, a clinical-stage biotech company established by pioneers in targeting the KRAS pathway, have announced the start of a Phase I clinical trial for KQB548, an investigational inhibitor aimed at treating KRAS G12D-mutated

Govt Boosts Healthcare Access, Focuses on Digital & Elderly Care

Under the Ayushman Bharat framework, the Union government has continuously sought to improve the primary to tertiary care continuum. Comprehensive primary care is being ensured through more than 1.79 lakh Ayushman Arogya Mandirs, and infrastructure

Sai, Centrix & Agility Form Integrated CMC Partnership

Today, Centrix Pharma Solutions, Sai Life Sciences, and Agility Life Sciences announced the formation of an Integrated CMC Partnership aimed at offering innovative biopharma firms comprehensive Chemistry, Manufacturing, and Controls (CMC) services

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.